CARDIFF ONCOLOGY INC shareholders Q3 2023

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 59 filers reported holding CARDIFF ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

CARDIFF ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
ELKHORN PARTNERS LIMITED PARTNERSHIP 45,000$630.04%
FinDec Wealth Services, Inc. 16,000$22,2400.02%
DENVER WEALTH MANAGEMENT, INC. 18,235$25,3470.02%
Atom Investors LP 18,298$25,4340.01%
Laurion Capital Management LP 722,100$1,003,7190.01%
MAI Capital Management 224,749$312,4010.01%
Callan Capital, LLC 31,147$43,2940.01%
GSA CAPITAL PARTNERS LLP 25,975$360.00%
Tortoise Investment Management, LLC 15,000$20,8500.00%
America First Investment Advisors, LLC 4,000$5,5600.00%
Moser Wealth Advisors, LLC 806$1,1200.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 65,558$91,1260.00%
BLAIR WILLIAM & CO/IL 130,500$181,3950.00%
Gladstone Institutional Advisory LLC 15,000$20,8500.00%
Bank of New York Mellon Corp 14,350$19,9460.00%
Citadel Advisors 20,300$28,2170.00%
Citadel Advisors 8,500$11,8150.00%
CAPSTONE INVESTMENT ADVISORS, LLC 51,190$71,1540.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 162,200$225,4580.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 47,500$66,0250.00%
External links

This page lists CARDIFF ONCOLOGY INC's shareholders in Q3 2023. To view CARDIFF ONCOLOGY INC's shareholder history, click here.